Work

A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.

Year: 1993

Type: article

Source: PubMed

Authors: R I Levy, A J Troendle, J M Fattu

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2411115313

FWCI: 10.62

Cites:

Cited by: 69

Related to: 10